While there is compelling evidence that the lipid phosphatase activity of PTEN, functionally opposing PI3K, is its dominant mechanism of tumour suppression [31,32,33], PTEN also has other potential mechanisms which may contribute [34,35]. The gene discussed is PTEN; the disease is neoplasm.